{{Rsnum
|rsid=8102476
|Chromosome=19
|position=38244973
|Orientation=plus
|GMAF=0.4591
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 25.7 | 49.6 | 24.8
| HCB | 13.1 | 37.2 | 49.6
| JPT | 15.0 | 50.4 | 34.5
| YRI | 66.7 | 32.0 | 1.4
| ASW | 56.1 | 36.8 | 7.0
| CHB | 13.1 | 37.2 | 49.6
| CHD | 15.6 | 52.3 | 32.1
| GIH | 12.9 | 56.4 | 30.7
| LWK | 56.9 | 38.5 | 4.6
| MEX | 27.6 | 43.1 | 29.3
| MKK | 45.5 | 43.6 | 10.9
| TSI | 41.2 | 46.1 | 12.7
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19767754
|Title=Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
|OA=1
}}

{{omim
|id=176807
|rsnum=8102476
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8102476
|overall_frequency_n=51
|overall_frequency_d=128
|overall_frequency=0.398438
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=39
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23573233
|Title=Characterization of SNPs Associated with Prostate Cancer in Men of Ashkenazic Descent from the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}